10/09/2024
3:16 PM | Stoke Therapeutics (Filer)
| Form S-3ASR | |
09/23/2024
3:22 PM | Skorpios Trust (Filed by)
Stoke Therapeutics (Subject)
| Form SC 13D/A | |
09/23/2024
3:23 PM | Blue Horizon Enterprise Ltd (Reporting)
Ezbon International Ltd (Reporting)
Montrago Trustees Ltd (Reporting)
Skorpios Trust (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/19/2024
4:23 PM | Blue Horizon Enterprise Ltd (Reporting)
Stoke Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/10/2024
3:17 PM | Stoke Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2024
3:20 PM | Stoke Therapeutics (Issuer)
Ticho Barry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2024
6:05 AM | Stoke Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
07/08/2024
3:32 PM | BlackRock Inc. (Filed by)
Stoke Therapeutics (Subject)
| Form SC 13G | |
06/20/2024
11:15 PM | Stoke Therapeutics (Filer)
| Form EFFECT | |
06/13/2024
3:06 PM | Stoke Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
06/07/2024
3:42 PM | Kaye Edward M. MD (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:32 PM | Harrison Seth Loring (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:35 PM | Stoke Therapeutics (Issuer)
Tulipano Stephen J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:37 PM | Allan Jonathan (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:39 PM | Stoke Therapeutics (Issuer)
Ticho Barry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:41 PM | Nash Huw M. (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:27 PM | Smith Julie (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:29 PM | Burstein Jennifer (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:16 PM | Krainer Adrian R. (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:18 PM | LEVIN ARTHUR A (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:19 PM | Stoke Therapeutics (Issuer)
TZIANABOS ARTHUR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
3:18 PM | Stoke Therapeutics (Issuer)
Ticho Barry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2024
3:15 PM | Allan Jonathan (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2024
3:17 PM | Kaye Edward M. MD (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2024
3:20 PM | Nash Huw M. (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2024
3:21 PM | Kaye Edward M. MD (Reporting)
Stoke Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/06/2024
6:05 AM | Stoke Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/23/2024
3:06 PM | Stoke Therapeutics (Filer)
| Form DEF 14A | |
04/23/2024
3:08 PM | Stoke Therapeutics (Filer)
| Form DEFA14A | |
04/23/2024
3:11 PM | Stoke Therapeutics (Filer)
| Form ARS | |
04/18/2024
3:16 PM | Blue Horizon Enterprise Ltd (Reporting)
Ezbon International Ltd (Reporting)
Montrago Trustees Ltd (Reporting)
Skorpios Trust (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/18/2024
3:18 PM | Skorpios Trust (Filed by)
Stoke Therapeutics (Subject)
| Form SC 13D/A | |
04/17/2024
3:17 PM | Ezbon International Ltd (Reporting)
Stoke Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/11/2024
3:06 PM | Stoke Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
04/03/2024
3:19 PM | Nash Huw M. (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2024
3:36 PM | Nash Huw M. (Reporting)
Stoke Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/28/2024
4:20 PM | Stoke Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/26/2024
3:47 PM | Stoke Therapeutics (Filer)
| Form 424B5 | |
03/25/2024
3:03 PM | Stoke Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2024
3:07 PM | Stoke Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2024
3:07 PM | Stoke Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
We recommended Nvidia in 2016, now we’re recommending this… (Ad) The AI boom is just getting started.
And the real wealth has still to be made… You must read this new presentation from Porter Stansberry. |
03/19/2024
7:29 PM | Allan Jonathan (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
7:30 PM | Kaye Edward M. MD (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
7:31 PM | Nash Huw M. (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
7:34 PM | Stoke Therapeutics (Issuer)
Ticho Barry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
7:36 PM | Stoke Therapeutics (Issuer)
Tulipano Stephen J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2024
9:36 AM | Cowen Financial Products LLC (Filed by)
Stoke Therapeutics (Subject)
| Form SC 13G | |
02/26/2024
9:38 AM | Cowen Financial Products LLC (Filed by)
Stoke Therapeutics (Subject)
| Form SC 13G/A | |
02/15/2024
3:17 PM | Stoke Therapeutics (Issuer)
TZIANABOS ARTHUR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
8:20 AM | Lynx1 Capital Management LP (Filed by)
Stoke Therapeutics (Subject)
| Form SC 13G/A | |
02/14/2024
6:44 AM | RTW INVESTMENTS, LP (Filed by)
Stoke Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024
1:51 PM | MORGAN STANLEY (Filed by)
Stoke Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024
8:49 AM | FMR LLC (Filed by)
Stoke Therapeutics (Subject)
| Form SC 13G/A | |
02/05/2024
3:32 PM | Stoke Therapeutics (Issuer)
Ticho Barry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/01/2024
3:49 PM | Stoke Therapeutics (Subject)
Ticho Barry (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024
7:09 AM | Stoke Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/05/2023
3:15 PM | Kaye Edward M. MD (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2023
3:17 PM | Nash Huw M. (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2023
3:18 PM | Stoke Therapeutics (Issuer)
Ticho Barry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2023
3:20 PM | Stoke Therapeutics (Issuer)
Tulipano Stephen J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/01/2023
8:04 AM | Stoke Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/17/2023
3:37 PM | Stoke Therapeutics (Subject)
| Form SC TO-I/A | |
11/07/2023
6:05 AM | Stoke Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/02/2023
8:01 AM | Stoke Therapeutics (Subject)
| Form SC TO-I | |
